Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 73.53% is in line with its 5-year average of 69.71%, around the middle of its 5-year range (52.79%–102.50%).
0.84% above its 12-month average of 72.91%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 102.50%.
GROSS MARGIN
73.53%
GROSS MARGIN AVG TTM
72.91%
GROSS MARGIN AVG 3Y
70.40%
GROSS MARGIN AVG 5Y
69.71%
GROSS MARGIN AVG 10Y
69.34%
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+0.84%
CURRENT VS 3Y AVG
+4.44%
CURRENT VS 5Y AVG
+5.48%
CURRENT VS 10Y AVG
+6.04%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
58.99%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+24.64%
vs the sector median at left
Teladoc Health, Inc.
Market Cap
$1.14B
Gross Margin
73.53%
TTM Avg
72.91%
3Y Avg
70.40%
5Y Avg
69.71%
Market Cap
$1.89B
Gross Margin
49.52%
TTM Avg
50.81%
3Y Avg
52.12%
5Y Avg
52.25%
Market Cap
$363.33M
Gross Margin
77.34%
TTM Avg
76.74%
3Y Avg
77.57%
5Y Avg
77.57%
Market Cap
$47.08M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.02B
Gross Margin
58.69%
TTM Avg
59.64%
3Y Avg
63.22%
5Y Avg
64.62%
Market Cap
$5.10B
Gross Margin
49.52%
TTM Avg
48.04%
3Y Avg
46.91%
5Y Avg
45.73%
Market Cap
$5.77B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
-67.67%
5Y Avg
-188.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Teladoc Health, Inc. (TDOC) | $1.14B | 73.53% | 72.91% | 70.40% | 69.71% |
| NRC Health (NRC)vs › | $479.36M | 56.33% | 58.27% | 60.30% | 61.48% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.89B | 49.52% | 50.81% | 52.12% | 52.25% |
| Shoulder Innovations, Inc. (SI)vs › | $363.33M | 77.34% | 76.74% | 77.57% | 77.57% |
| PDS Biotechnology Corporation (PDSB)vs › | $47.08M | 0.00% | 0.00% | 0.00% | 0.00% |
| TransMedics Group, Inc. (TMDX)vs › | $3.02B | 58.69% | 59.64% | 63.22% | 64.62% |
| Doximity, Inc. (DOCS)vs › | $5.02B | 88.07% | 89.65% | 88.97% | 88.20% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.10B | 49.52% | 48.04% | 46.91% | 45.73% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.77B | 0.00% | 0.00% | -67.67% | -188.00% |
| Chemed Corporation (CHE)vs › | $6.53B | 30.44% | 32.55% | 34.06% | 34.32% |
Gross Margin
73.5%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 102.50% |
| 2026-03-31 | 52.79% |
| 2025-12-31 | 69.32% |
| 2025-09-30 | 70.12% |
| 2025-06-30 | 69.85% |
| 2025-03-31 | 68.73% |
| 2024-12-31 | 70.50% |
| 2024-09-30 | 71.94% |
| 2024-06-30 | 70.73% |
| 2024-03-31 | 69.89% |
| 2023-12-31 | 70.72% |
| 2023-09-30 | 71.83% |
| 2023-06-30 | 70.79% |
| 2023-03-31 | 69.79% |
| 2022-12-31 | 70.38% |
| 2022-09-30 | 69.64% |
| 2022-06-30 | 69.20% |
| 2022-03-31 | 66.92% |
| 2021-12-31 | 68.43% |
| 2021-09-30 | 67.60% |
| 2021-06-30 | 68.15% |
| 2021-03-31 | 67.83% |
| 2020-12-31 | 67.93% |
| 2020-09-30 | 63.74% |
| 2020-06-30 | 62.34% |
| 2020-03-31 | 59.97% |
| 2019-12-31 | 64.63% |
| 2019-09-30 | 68.98% |
| 2019-06-30 | 68.04% |
| 2019-03-31 | 65.25% |
| 2018-12-31 | 67.39% |
| 2018-09-30 | 69.21% |
| 2018-06-30 | 70.72% |
| 2018-03-31 | 70.04% |
| 2017-12-31 | 70.55% |
| 2017-09-30 | 75.61% |
| 2017-06-30 | 77.52% |
| 2017-03-31 | 71.70% |
| 2016-12-31 | 73.20% |
| 2016-09-30 | 78.04% |
| 2016-06-30 | 73.98% |
| 2016-03-31 | 70.46% |
| 2015-12-31 | 71.39% |
| 2015-09-30 | 77.53% |
| 2015-06-30 | 73.78% |
| 2015-03-31 | 67.97% |
| 2014-12-31 | 70.84% |
| 2014-09-30 | 80.28% |
| 2014-06-30 | 80.30% |
| 2014-03-31 | 78.93% |
